Boehringer Ingelheim Pharmaceuticals, Inc. recalls Mirapex (pramipexole dihydrochloride) Tablets, 1 mg, 100-count unit-dose tablets per folding carton, Rx only, Distribute
Recalled March 20, 2019 · FDA recall D-0991-2019 · Boehringer Ingelheim Pharmaceuticals
Hazard
Failed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing. · FDA Class III
Units
112 folding cartons
Sold at
Nationwide in the USA
Description
Failed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing.
Product
Mirapex (pramipexole dihydrochloride) Tablets, 1 mg, 100-count unit-dose tablets per folding carton, Rx only, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Made in Germany, NDC 0597-0190-61.
Manufacturer(s)
Boehringer Ingelheim Pharmaceuticals, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →